Evidence map›Paper›PMID 26457228›Full record

ArticleJournal of AIDS & clinical research2015

A Novel Point-of-Care BioNanoSensor for Rapid HIV Detection and Treatment Monitoring.

Tomasz Rozmyslowicz, Johann deSa, Ryszard Lec, Glen N Gaulton

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of AIDS & clinical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tomasz RozmyslowiczDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia, USA.
Johann deSaSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, USA.
Ryszard LecSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, USA.
Glen N GaultonDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia, USA.

Funding

NANO-CHIP HIV DETECTION IN VULNERABLE POPULATIONSR21AI094661 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GAULTON, GLEN N. · 2010 to 2011
$428k
NIAID NIH HHS R21 AI094661
6 · The paper itself

Abstract

We report here a new diagnostic approach to the direct detection of HIV in blood or other body fluids that is rapid, sensitive and potentially applicable in a point-of-care setting. The approach follows on the development of a novel BioNanoSensor (BNS) device that utilizes piezoelectric technology to detect the presence of the HIV surface glycoprotein gp120 in a nanoscale format. The detection range of the BNS device for the biomarker gp120 displayed a low-end sensitivity of 6.5×10

Indexed as

BioNanoSensorsElectronic Measurement SystemHIV-1 infectionHIV detectionHIV treatment monitoringPiezoelectric high frequency technologyPolyclonal sheep anti-HIV-1 gp120

Identifiers

PMID26457228
PMCPMC4596080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.